Home/Filings/4/0001728117-21-000050
4//SEC Filing

Carter Laura 4

Accession 0001728117-21-000050

CIK 0001728117other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:15 PM ET

Size

7.0 KB

Accession

0001728117-21-000050

Insider Transaction Report

Form 4
Period: 2021-05-03
Carter Laura
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-05-03+10,82072,683 total
  • Award

    Stock Option (Right to Buy)

    2021-05-03+31,75031,750 total
    Exercise: $8.70Exp: 2031-05-03Common Stock (31,750 underlying)
Footnotes (2)
  • [F1]Represents a restricted stock unit award, which will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.
  • [F2]25% of the total number of shares subject to the option will vest on May 3, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001858178

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:15 PM ET
Size
7.0 KB